Search results
Results from the WOW.Com Content Network
The Executive Order also provided explicit genetic privacy regulations within the federal government. [3] The second piece of federal legislation to address the use of genetic information and discrimination in the United States was the Genetic Information Nondiscrimination Act (GINA) of 2008.
Executive Order 14168, titled "Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government", is an executive order issued by Donald Trump on January 20, 2025, [1] the day of his second inauguration as president of the United States.
The Genetic Information Nondiscrimination Act of 2008 (Pub. L. 110–233 (text), 122 Stat. 881, enacted May 21, 2008, GINA / ˈ dʒ iː. n ə / JEE-nə), is an Act of Congress in the United States designed to prohibit some types of genetic discrimination.
Bipartisan bills introduced in Congress Thursday would effectively ban a Chinese genomics firm from doing business in America. Intel officials have warned China is grabbing U.S. genetic info.
A congressional committee focused on China has introduced a bill that would restrict federally funded medical providers from allowing China's BGI Group, WuXi Apptec and other biotech companies ...
Wade legalized abortion in the United States. Five years later, the first successful human in vitro fertilization resulted in the birth of Louise Brown in England. These developments prompted the federal government to create regulations barring the use of federal funds for research that experimented on human embryos. [3]
Eugenics, the set of beliefs and practices which aims at improving the genetic quality of the human population, [1] [2] played a significant role in the history and culture of the United States from the late 19th century into the mid-20th century. [3]
As with all utility patents in the United States, a biological patent provides the patent holder with the right to exclude others from making, using, selling, or importing the claimed invention or discovery in biology for a limited period of time - for patents filed after 1998, 20 years from the filing date.